SOS1 inhibitor (Satyarx)

N/A

Report date: 2025/01/26 17:12:46
NME

Base Information

Drug NameSOS1 inhibitor (Satyarx)
Drug Alias NameSOS1 inhibitor (Satyarx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase; ERK1/ERK2 inhibitorsSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1Mitogen-activated protein kinase; ERK1/ERK2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSatyarx Pharma Innovations Pvt Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A